Rhodes L E, Diffey B L
Department of Dermatology, Royal Liverpool, University Hospital, U.K.
Br J Dermatol. 1997 Jan;136(1):12-7.
We report the quantification of skin surface thickness of topical agents by in vivo fluorescence spectroscopy, and demonstrate its potential uses for assessment of application technique and substantivity. A series of studies were performed on forearm skin of eight normal subjects using three creams which have intrinsic fluorescence: a sunscreen (Neutrogena SPF15 waterproof cream), an antiseptic (Hewlett's cream) and a steroid (Trimovate (clobetasone butyrate) cream). Initially, the dose-response relationship was established for each agent by applying a series of five doses (0.5-8 microliters/cm2) and measuring cream fluorescence using appropriate excitation and emission wavelengths. Next, the influence of application technique was examined by comparing light application of cream with firm rubbing. Substantivity of the three creams was assessed on dry skin by taking fluorescence measurements over 8 h. Finally, water resistance of 2 microliters/cm2 of sunscreen and antiseptic cream were compared by measuring fluorescence after each of four water immersions. The fluorescence intensity was strongly correlated with the logarithm of surface density. r = 1.0, 0.92 and 0.98 for sunscreen, antiseptic and steroid creams, respectively, allowing derivation of a simple expression for equivalent thickness. Surface thickness of each cream was lower following firm rubbing compared with light application (P < 0.01). The rate constants for reduction of surface density of the three creams with time on dry skin were not significantly different. However, on washed skin, the rate constant was higher for Hewlett's than Neutrogena cream (0.503 and 0.243 h. respectively, P = 0.02), with a higher rate for each cream on wet compared with dry skin (P < 0.001). Hence, fluorescence spectroscopy is a simple, rapid method for measurement of cream thickness in vivo. The many potential applications in dermatology include quantitative assessment of application technique and substantivity of topical agents.
我们报告了通过体内荧光光谱法对局部用药的皮肤表面厚度进行量化,并证明了其在评估涂抹技术和药物附着性方面的潜在用途。使用三种具有固有荧光的乳膏,对八名正常受试者的前臂皮肤进行了一系列研究:一种防晒霜(露得清SPF15防水霜)、一种防腐剂(休利特乳膏)和一种类固醇(适确得(丁酸氯倍他松)乳膏)。最初,通过涂抹一系列五个剂量(0.5 - 8微升/平方厘米)并使用适当的激发和发射波长测量乳膏荧光,为每种药物建立剂量 - 反应关系。接下来,通过比较轻柔涂抹乳膏与用力揉搓来检查涂抹技术的影响。通过在8小时内进行荧光测量,评估了三种乳膏在干性皮肤上的附着性。最后,通过在四次水浸每次后测量荧光,比较了2微升/平方厘米的防晒霜和防腐剂乳膏的防水性。荧光强度与表面密度的对数高度相关。防晒霜、防腐剂和类固醇乳膏的r值分别为1.0、0.92和0.98,从而可以推导出等效厚度的简单表达式。与轻柔涂抹相比,用力揉搓后每种乳膏的表面厚度更低(P < 0.01)。三种乳膏在干性皮肤上表面密度随时间降低的速率常数无显著差异。然而,在清洗后的皮肤上,休利特乳膏的速率常数高于露得清乳膏(分别为0.503和0.243小时,P = 0.02),并且每种乳膏在湿性皮肤上的速率高于干性皮肤(P < 0.001)。因此,荧光光谱法是一种在体内测量乳膏厚度的简单、快速方法。在皮肤病学中的许多潜在应用包括对涂抹技术和局部用药附着性的定量评估。